Get the Stockscreener App
91.23
0.23%
0.21
After Hours:
91.23
Amedisys Inc stock is traded at $91.23, with a volume of 109.34K.
It is up +0.23% in the last 24 hours and down -6.16% over the past month.
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
See More
Previous Close:
$91.02
Open:
$91.33
24h Volume:
109.34K
Relative Volume:
0.26
Market Cap:
$2.99B
Revenue:
$2.32B
Net Income/Loss:
$82.93M
P/E Ratio:
1,303.29
EPS:
0.07
Net Cash Flow:
$203.54M
1W Performance:
+1.37%
1M Performance:
-6.16%
6M Performance:
-5.20%
1Y Performance:
-3.04%
1-Day Range:
$90.91
$91.48
1-Week Range:
$89.78
$91.76
52-Week Range:
$88.81
$98.95
Amedisys Inc Stock (AMED) Company Profile
Name
Amedisys Inc
Sector
Industry
Phone
(225) 292-2031
Address
3854 AMERICAN WAY, BATON ROUGE, LA
Compare AMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
91.23 | 2.99B | 2.32B | 82.93M | 203.54M | 0.07 |
|
HCA
Hca Healthcare Inc
|
325.47 | 83.32B | 69.62B | 5.93B | 5.88B | 20.33 |
|
THC
Tenet Healthcare Corp
|
141.98 | 13.97B | 20.97B | 3.13B | 2.39B | 4.33 |
|
DVA
Davita Inc
|
165.63 | 13.81B | 12.67B | 827.68M | 1.42B | 5.03 |
|
UHS
Universal Health Services Inc
|
203.50 | 13.34B | 15.42B | 1.03B | 956.84M | 9.53 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.48 | 13.16B | 20.87B | 715.14M | 1.67B | 0.8156 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-07-23 | Downgrade | Truist | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Mar-13-23 | Initiated | Barclays | Equal Weight |
| Oct-27-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-02-22 | Downgrade | UBS | Neutral → Sell |
| Jun-29-22 | Initiated | Stifel | Hold |
| Jun-21-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-01-22 | Upgrade | UBS | Sell → Neutral |
| Feb-25-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Feb-25-22 | Reiterated | Credit Suisse | Outperform |
| Feb-25-22 | Reiterated | Oppenheimer | Outperform |
| Feb-25-22 | Reiterated | RBC Capital Mkts | Outperform |
| Feb-25-22 | Reiterated | Raymond James | Outperform |
| Feb-25-22 | Reiterated | Truist | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-24-21 | Initiated | UBS | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-10-21 | Reiterated | The Benchmark Company | Buy |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-20-20 | Resumed | Barclays | Overweight |
| Jul-30-20 | Reiterated | The Benchmark Company | Buy |
| Jun-18-20 | Upgrade | The Benchmark Company | Hold → Buy |
| May-07-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-09-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Jan-17-20 | Initiated | Credit Suisse | Outperform |
| Nov-01-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-22-19 | Resumed | Stephens | Equal-Weight |
| Sep-17-19 | Initiated | Deutsche Bank | Buy |
| May-02-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-14-18 | Initiated | Barclays | Equal Weight |
| Nov-16-18 | Initiated | UBS | Neutral |
| Oct-30-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Jul-03-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-19-18 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Nov-09-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-08-17 | Reiterated | Mizuho | Buy |
| Nov-02-17 | Upgrade | The Benchmark Company | Hold → Buy |
| Aug-21-17 | Initiated | BofA/Merrill | Neutral |
View All
Amedisys Inc Stock (AMED) Latest News
Citigroup Inc. Raises Holdings in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ blocks UnitedHealth Group and Amedisys merger - The Ticker
US sues to block UnitedHealth's $3.3 billion purchase of Amedisys - MSN
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal - MSN
Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys - MSN
Why the DOJ’s Lawsuit Against the UGH-Amedisys Merger May Not Go Anywhere - MedCity News
US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports - MSN
Alpine Associates Management Inc. Sells 420,180 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ sues UnitedHealth amid $3.3 billion bid to buy home care giant Amedisys - MSN
DOJ Challenges UnitedHealth And Amedisys Merger - Evrim Ağacı
Principal Financial Group Inc. Reduces Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
U.S. Justice Department moves to block big healthcare purchase - Nevada Current
ACA subsidy optimism and a fiery antitrust speech - STAT
Amedisys stock touches 52-week low at $89.54 amid market shifts - Investing.com
Inside the Justice Department’s Amedisys-Optum Lawsuit - Hospice News
LMR Partners LLP Decreases Stock Holdings in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Amedisys Earnings: An Early Look - AOL
ING Groep NV Cuts Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Justice Department and four Attorneys General block $3.3 billion acquisition of Amedisys Inc. - MSN
DOJ is suing to block UnitedHealth's $3.3 billion purchase of Amedisys - Fortune
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape - AOL
Evaluating The DOJ’s Arguments Against The UnitedHealth Group-Amedisys Deal - Home Health Care News
Justice Department sues to block UnitedHealth Group’s $3.3 billion purchase of Amedisys - Nashua Telegraph
Amedisys, Inc. (NASDAQ:AMED) Short Interest Up 37.8% in October - MarketBeat
DOJ Sues to Stop UnitedHealth's Amedisys Acquisition - Newser
Juniper Networks falls as DOJ sues to block Amedisys sale to UnitedHealth - MSN
DOJ files lawsuit to block UnitedHealth from purchasing Amedisys - The San Joaquin Valley Sun
DOJ sues to block UnitedHealth Group’s acquisition of Amedisys - BenefitsPro
DOJ sues to block UnitedHealth’s acquisition of Amedisys - Business Insurance
DOJ sues to block UnitedHealth's acquisition of Amedisys - Healthcare Finance News
$3B Health Care Merger Would Be Bad For New Jersey, Other States: Feds - Patch
New York Attorney General Letitia James joins lawsuit against UnitedHealth Group merger - CNYcentral.com
DOJ prepares lawsuit to block UnitedHealth Group’s acquisition of Amedisys - BenefitsPro
Justice Department sues to block United Health merger with Amedisys - ConsumerAffairs
Amedisys Inc Stock (AMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):